AU5688999A - Formamide compounds as therapeutic agents - Google Patents

Formamide compounds as therapeutic agents

Info

Publication number
AU5688999A
AU5688999A AU56889/99A AU5688999A AU5688999A AU 5688999 A AU5688999 A AU 5688999A AU 56889/99 A AU56889/99 A AU 56889/99A AU 5688999 A AU5688999 A AU 5688999A AU 5688999 A AU5688999 A AU 5688999A
Authority
AU
Australia
Prior art keywords
therapeutic agents
formamide compounds
formamide
compounds
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56889/99A
Inventor
Marc Werner Andersen
Robert Carl Andrews
Dulce Garrido Babacz
Joseph Howing Chan
David John Cowan
Michael David Gaul
Darryl Lynn Mcdougald
David Lee Musso
Michael Howard Rabinowitz
Jennifer Badiang Stanford
Robert William Wiethe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818605.9A external-priority patent/GB9818605D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU5688999A publication Critical patent/AU5688999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
AU56889/99A 1998-08-26 1999-08-25 Formamide compounds as therapeutic agents Abandoned AU5688999A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9795998P 1998-08-26 1998-08-26
US60097959 1998-08-26
GBGB9818605.9A GB9818605D0 (en) 1998-08-26 1998-08-26 Formamide compounds as therepeutic agents
GB9818605 1998-08-26
PCT/US1999/019304 WO2000012466A1 (en) 1998-08-26 1999-08-25 Formamide compounds as therapeutic agents

Publications (1)

Publication Number Publication Date
AU5688999A true AU5688999A (en) 2000-03-21

Family

ID=26314263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56889/99A Abandoned AU5688999A (en) 1998-08-26 1999-08-25 Formamide compounds as therapeutic agents

Country Status (2)

Country Link
AU (1) AU5688999A (en)
WO (1) WO2000012466A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
CN107739321A (en) * 2017-09-22 2018-02-27 山东金城医药化工有限公司 The preparation method of the sulfonic acid aminobutyric acid of 2 amino 3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199902063T2 (en) * 1997-02-26 1999-12-21 Glaxo Group Limited Inverse hydroxamate derivatives as metalloprotease inhibitors.

Also Published As

Publication number Publication date
WO2000012466A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
GB9812038D0 (en) Therapeutic compound
AU3997700A (en) Anti-first-pass effect compounds
AU2451500A (en) Therapeutic agents
AU2656799A (en) Metal-thiols as imminomodulating agents
GB9900222D0 (en) Therapeutic compounds
GB9808665D0 (en) Therapeutic compounds
AU5973600A (en) Therapeutic agents
GB9824897D0 (en) Therapeutic compounds
AU5688999A (en) Formamide compounds as therapeutic agents
GB9810920D0 (en) Therapeutic use
GB9920162D0 (en) Formamide compounds as therapeutic agents
AU6150200A (en) Therapeutic agents
AU5574999A (en) Formamide compounds as therapeutic agents
GB9808667D0 (en) Therapeutic compounds
AU5817400A (en) Therapeutic agents
GB9818608D0 (en) Formamide compounds as therapeutic agents
GB9811624D0 (en) Therapeutic use
AU5582899A (en) Formamides as therapeutic agents
AUPP504698A0 (en) Therapeutic compounds
AUPP311498A0 (en) Therapeutic compounds
AUPP153098A0 (en) Therapeutic compounds
AUPP152998A0 (en) Therapeutic compounds
AU5817500A (en) Therapeutic agents
AU6302300A (en) Therapeutic agents
AUPP836999A0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase